Company / Free Cash Flow
ALX ONCOLOGY HOLDINGS INC Free Cash Flow History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$90.7M
FY2022
5-year range
-$90.7M / -$13.8M
FY2020-FY2022
Trend
-520.8%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow changed -521% YoY in FY2022, a notable deviation from the 2-year average annual change of -263%.
Based on SEC 10-K filings.
-$91M in FY2022.
Declined from -$14M to -$91M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, free cash flow decreased 520.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$90.7M | -520.8% |
| FY2021 | -$14.6M | -5.5% |
| FY2020 | -$13.8M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026